These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
218 related articles for article (PubMed ID: 39227502)
1. Association of quantitative histopathology measurements with antemortem medial temporal lobe cortical thickness in the Alzheimer's disease continuum. Denning AE; Ittyerah R; Levorse LM; Sadeghpour N; Athalye C; Chung E; Ravikumar S; Dong M; Duong MT; Li Y; Ilesanmi A; Sreepada LP; Sabatini P; Lowe M; Bahena A; Zablah J; Spencer BE; Watanabe R; Kim B; Sørensen MH; Khandelwal P; Brown C; Hrybouski S; Xie SX; de Flores R; Robinson JL; Schuck T; Ohm DT; Arezoumandan S; Porta S; Detre JA; Insausti R; Wisse LEM; Das SR; Irwin DJ; Lee EB; Wolk DA; Yushkevich PA Acta Neuropathol; 2024 Sep; 148(1):37. PubMed ID: 39227502 [TBL] [Abstract][Full Text] [Related]
2. Contribution of mixed pathology to medial temporal lobe atrophy in Alzheimer's disease. de Flores R; Wisse LEM; Das SR; Xie L; McMillan CT; Trojanowski JQ; Robinson JL; Grossman M; Lee E; Irwin DJ; Yushkevich PA; Wolk DA Alzheimers Dement; 2020 Jun; 16(6):843-852. PubMed ID: 32323446 [TBL] [Abstract][Full Text] [Related]
3. Downstream effects of polypathology on neurodegeneration of medial temporal lobe subregions. Wisse LEM; Ravikumar S; Ittyerah R; Lim S; Lane J; Bedard ML; Xie L; Das SR; Schuck T; Grossman M; Lee EB; Tisdall MD; Prabhakaran K; Detre JA; Mizsei G; Trojanowski JQ; Artacho-Pérula E; de Iñiguez de Onzono Martin MM; M Arroyo-Jiménez M; Muñoz Lopez M; Molina Romero FJ; P Marcos Rabal M; Cebada Sánchez S; Delgado González JC; de la Rosa Prieto C; Córcoles Parada M; Wolk DA; Irwin DJ; Insausti R; Yushkevich PA Acta Neuropathol Commun; 2021 Jul; 9(1):128. PubMed ID: 34289895 [TBL] [Abstract][Full Text] [Related]
4. Ex vivo MRI atlas of the human medial temporal lobe: characterizing neurodegeneration due to tau pathology. Ravikumar S; Wisse LEM; Lim S; Ittyerah R; Xie L; Bedard ML; Das SR; Lee EB; Tisdall MD; Prabhakaran K; Lane J; Detre JA; Mizsei G; Trojanowski JQ; Robinson JL; Schuck T; Grossman M; Artacho-Pérula E; de Onzoño Martin MMI; Del Mar Arroyo Jiménez M; Muñoz M; Romero FJM; Del Pilar Marcos Rabal M; Sánchez SC; González JCD; de la Rosa Prieto C; Parada MC; Irwin DJ; Wolk DA; Insausti R; Yushkevich PA Acta Neuropathol Commun; 2021 Oct; 9(1):173. PubMed ID: 34689831 [TBL] [Abstract][Full Text] [Related]
5. Reduced Repetition Suppression in Aging is Driven by Tau-Related Hyperactivity in Medial Temporal Lobe. Adams JN; Maass A; Berron D; Harrison TM; Baker SL; Thomas WP; Stanfill M; Jagust WJ J Neurosci; 2021 Apr; 41(17):3917-3931. PubMed ID: 33731446 [TBL] [Abstract][Full Text] [Related]
6. Pathological drivers of neurodegeneration in suspected non-Alzheimer's disease pathophysiology. Wisse LEM; de Flores R; Xie L; Das SR; McMillan CT; Trojanowski JQ; Grossman M; Lee EB; Irwin D; Yushkevich PA; Wolk DA; Alzheimers Res Ther; 2021 May; 13(1):100. PubMed ID: 33990226 [TBL] [Abstract][Full Text] [Related]
7. Entorhinal Tau Pathology, Episodic Memory Decline, and Neurodegeneration in Aging. Maass A; Lockhart SN; Harrison TM; Bell RK; Mellinger T; Swinnerton K; Baker SL; Rabinovici GD; Jagust WJ J Neurosci; 2018 Jan; 38(3):530-543. PubMed ID: 29192126 [TBL] [Abstract][Full Text] [Related]
8. Medial Temporal Lobe Networks in Alzheimer's Disease: Structural and Molecular Vulnerabilities. de Flores R; Das SR; Xie L; Wisse LEM; Lyu X; Shah P; Yushkevich PA; Wolk DA J Neurosci; 2022 Mar; 42(10):2131-2141. PubMed ID: 35086906 [TBL] [Abstract][Full Text] [Related]
15. Progressive medial temporal lobe atrophy during preclinical Alzheimer's disease. Pettigrew C; Soldan A; Sloane K; Cai Q; Wang J; Wang MC; Moghekar A; Miller MI; Albert M; Neuroimage Clin; 2017; 16():439-446. PubMed ID: 28879085 [TBL] [Abstract][Full Text] [Related]
16. Application of deep learning to understand resilience to Alzheimer's disease pathology. Lee CS; Latimer CS; Henriksen JC; Blazes M; Larson EB; Crane PK; Keene CD; Lee AY Brain Pathol; 2021 Nov; 31(6):e12974. PubMed ID: 34009663 [TBL] [Abstract][Full Text] [Related]
17. Medial temporal lobe subregional morphometry using high resolution MRI in Alzheimer's disease. Wolk DA; Das SR; Mueller SG; Weiner MW; Yushkevich PA; Neurobiol Aging; 2017 Jan; 49():204-213. PubMed ID: 27836336 [TBL] [Abstract][Full Text] [Related]
18. Increased Medial Temporal Tau Positron Emission Tomography Uptake in the Absence of Amyloid-β Positivity. Costoya-Sánchez A; Moscoso A; Silva-Rodríguez J; Pontecorvo MJ; Devous MD; Aguiar P; Schöll M; Grothe MJ; JAMA Neurol; 2023 Oct; 80(10):1051-1061. PubMed ID: 37578787 [TBL] [Abstract][Full Text] [Related]
19. Early stages of tau pathology and its associations with functional connectivity, atrophy and memory. Berron D; Vogel JW; Insel PS; Pereira JB; Xie L; Wisse LEM; Yushkevich PA; Palmqvist S; Mattsson-Carlgren N; Stomrud E; Smith R; Strandberg O; Hansson O Brain; 2021 Oct; 144(9):2771-2783. PubMed ID: 33725124 [TBL] [Abstract][Full Text] [Related]
20. Longitudinal and cross-sectional structural magnetic resonance imaging correlates of AV-1451 uptake. Das SR; Xie L; Wisse LEM; Ittyerah R; Tustison NJ; Dickerson BC; Yushkevich PA; Wolk DA; Neurobiol Aging; 2018 Jun; 66():49-58. PubMed ID: 29518752 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]